A study of poliovaccination in infancy: excretion following challenge with live virus by children given killed or living poliovaccine.
作者信息
Henry J L, Jaikaran E S, Davies J R, Tomlinson A J, Mason P J, Barnes J M, Beale A J
出版信息
J Hyg (Lond). 1966 Mar;64(1):105-20. doi: 10.1017/s0022172400040389.
Abstract
摘要
相似文献
1
A study of poliovaccination in infancy: excretion following challenge with live virus by children given killed or living poliovaccine.婴儿期脊髓灰质炎疫苗接种研究：接种灭活或减毒脊髓灰质炎疫苗的儿童经活病毒攻击后的排泄情况
J Hyg (Lond). 1966 Mar;64(1):105-20. doi: 10.1017/s0022172400040389.
2
Effect of different immunisation schedules on the excretion and reversion of oral poliovaccine strains.不同免疫程序对口服脊髓灰质炎疫苗株排泄及回复突变的影响。
J Med Virol. 2005 Jan;75(1):153-60. doi: 10.1002/jmv.20250.
3
Poliomyelitis antibody titres in children and effect of live and inactivated poliovaccine.
Lancet. 1969 Mar 15;1(7594):564-6. doi: 10.1016/s0140-6736(69)91970-9.
4
An Introduction to Poliovirus: Pathogenesis, Vaccination, and the Endgame for Global Eradication.脊髓灰质炎病毒简介：发病机制、疫苗接种及全球根除的最终目标
Methods Mol Biol. 2016;1387:1-10. doi: 10.1007/978-1-4939-3292-4_1.
5
Immunoglobulin response in serum and secretions after immunization with live and inactivated poliovaccine and natural infection.用活疫苗和灭活脊髓灰质炎疫苗免疫及自然感染后血清和分泌物中的免疫球蛋白反应。
N Engl J Med. 1968 Oct 24;279(17):893-900. doi: 10.1056/NEJM196810242791701.
6
Vaccination with attenuated type I poliovirus, the Chat strain. II. Transmission of virus in relation to age.使用减毒I型脊髓灰质炎病毒Chat株进行疫苗接种。II. 病毒传播与年龄的关系。
Acta Paediatr Scand. 1966 Jul;55(4):416-21. doi: 10.1111/j.1651-2227.1966.tb08814.x.
7
Some results of the work on mass immunization in the Soviet Union with live poliovirus vaccine prepared from Sabin strains.苏联使用由萨宾毒株制备的脊髓灰质炎活疫苗进行大规模免疫接种工作的一些成果。
Bull World Health Organ. 1961;25(1):79-91.
8
Booster effect of oral poliovaccine. Trials in persons previously immunized with inactivated vaccine.口服脊髓灰质炎疫苗的加强效果。在先前接种过灭活疫苗的人群中进行的试验。
Am J Dis Child. 1969 Feb;117(2):161-8.
9
10
Vaccination with attenuated type I poliovirus, the Chat strain. I. A study of 20 families.使用减毒I型脊髓灰质炎病毒（Chat株）进行疫苗接种。I. 对20个家庭的研究。
Acta Paediatr Scand. 1966 Jul;55(4):405-15. doi: 10.1111/j.1651-2227.1966.tb08813.x.
引用本文的文献
1
Development of RT-PCR Assays for Simple Detection and Identification of Sabin Virus Contaminants in the Novel Oral Poliovirus Vaccines.用于新型口服脊髓灰质炎病毒疫苗中萨宾病毒污染物简易检测与鉴定的逆转录聚合酶链反应检测方法的开发
Vaccines (Basel). 2025 Jan 15;13(1):75. doi: 10.3390/vaccines13010075.
2
Improvement of the qmosRT-PCR Assay and Its Application for the Detection and Quantitation of the Three Serotypes of the Novel Oral Polio Vaccine in Stool Samples.qmosRT-PCR检测方法的改进及其在粪便样本中新型口服脊髓灰质炎疫苗三种血清型检测和定量分析中的应用
Vaccines (Basel). 2023 Nov 19;11(11):1729. doi: 10.3390/vaccines11111729.
3
The Fight against Poliovirus Is Not Over.对抗脊髓灰质炎病毒的斗争尚未结束。
Microorganisms. 2023 May 17;11(5):1323. doi: 10.3390/microorganisms11051323.
4
Establishment of isotype-switched, antigen-specific B cells in multiple mucosal tissues using non-mucosal immunization.利用非黏膜免疫在多个黏膜组织中建立同种型转换的、抗原特异性B细胞。
NPJ Vaccines. 2023 May 31;8(1):80. doi: 10.1038/s41541-023-00677-z.
5
Mucosal immunity to poliovirus.肠道黏膜对脊髓灰质炎病毒的免疫。
Mucosal Immunol. 2022 Jan;15(1):1-9. doi: 10.1038/s41385-021-00428-0. Epub 2021 Jul 8.
6
Reduced mucosal immunity to poliovirus after cessation of trivalent oral polio vaccine.三价口服脊髓灰质炎疫苗停用后，对脊髓灰质炎病毒的黏膜免疫力降低。
Hum Vaccin Immunother. 2021 Aug 3;17(8):2560-2567. doi: 10.1080/21645515.2021.1911213. Epub 2021 Apr 13.
7
Limited available evidence supports theoretical predictions of reduced vaccine efficacy at higher exposure dose.有限的可用证据支持了在更高暴露剂量下疫苗效力降低的理论预测。
Sci Rep. 2019 Mar 1;9(1):3203. doi: 10.1038/s41598-019-39698-x.
8
Assessing the stability of polio eradication after the withdrawal of oral polio vaccine.评估停用口服脊髓灰质炎疫苗后消灭脊灰的稳定性。
PLoS Biol. 2018 Apr 27;16(4):e2002468. doi: 10.1371/journal.pbio.2002468. eCollection 2018 Apr.
9
Causes of impaired oral vaccine efficacy in developing countries.发展中国家口腔疫苗效力受损的原因。
Future Microbiol. 2018 Jan;13(1):97-118. doi: 10.2217/fmb-2017-0128. Epub 2017 Dec 8.
10
Exploring the relationship between polio type 2 serum neutralizing antibodies and intestinal immunity using data from two randomized controlled trials of new bOPV-IPV immunization schedules.利用两种新型 bOPV-IPV 免疫程序随机对照试验的数据探索 2 型脊灰血清中和抗体与肠道免疫之间的关系。
Vaccine. 2017 Dec 19;35(52):7283-7291. doi: 10.1016/j.vaccine.2017.11.006. Epub 2017 Nov 14.
本文引用的文献
1
Virus Neutralization Test in a Capillary Tube.毛细管中的病毒中和试验。
Science. 1962 Oct 19;138(3538):448. doi: 10.1126/science.138.3538.448.
2
Some observations on the use of secondary monkey kidney cell cultures for the routine diagnosis of virus diseases.关于使用二代猴肾细胞培养物进行病毒疾病常规诊断的一些观察
Mon Bull Minist Health Public Health Lab Serv. 1960 Apr;19:49-54.
3
THE FUTURE OF INACTIVATED POLIOMYELITIS VACCINES.灭活脊髓灰质炎疫苗的未来
Proc R Soc Med. 1964 Jun;57(6):462-4. doi: 10.1177/003591576405700609.
4
INTERNATIONAL STANDARDS FOR ANTI-POLIOVIRUS SERA TYPES 1, 2 AND 3.1型、2型和3型抗脊髓灰质炎病毒血清国际标准
Bull World Health Organ. 1963;29(6):711-20.
5
New quadruple vaccine.新型四联疫苗。
Lancet. 1962 May 5;1(7236):939-41. doi: 10.1016/s0140-6736(62)91974-8.
6
British standard poliomyelitis antisera types 1, 2, and 3.英国标准1型、2型和3型脊髓灰质炎抗血清
Br Med J. 1959 Jun 20;1(5137):1549-53. doi: 10.1136/bmj.1.5137.1549.
7
Response of infants to a third dose of poliomyelitis vaccine given 10 to 12 months after primary immunization.婴儿在初次免疫后10至12个月接种第三剂脊髓灰质炎疫苗的反应。
Br Med J. 1959 Mar 14;1(5123):680-2. doi: 10.1136/bmj.1.5123.680.
8
Serological response of infants to poliomyelitis vaccine.婴儿对脊髓灰质炎疫苗的血清学反应。
Br Med J. 1958 Jul 12;2(5088):68-71. doi: 10.1136/bmj.2.5088.68.
9
Serum gamma globulin levels in normal infants.正常婴儿的血清γ球蛋白水平。
Pediatrics. 1955 Nov;16(5):575-84.
10
Immunization of young babies against diphtheria.给幼儿接种白喉疫苗。
Br Med J. 1954 Feb 27;1(4860):476-81. doi: 10.1136/bmj.1.4860.476.
Zotero 插件